are approved for venous thromboembolism (VTE) prophylaxis. Which agent is superior remains controversial. OBJECTIVE: To compare the effectiveness, complications, and costs of UFH and LMWH as VTE ...
Venous thromboembolism (VTE) and complications due to VTE are a major cause of morbidity and mortality in hospitalized patients. The multinational ENDORSE study examined the prevalence of risk ...
Conclusion In hospitalized patients with cirrhosis who have elevated INR values, pharmacologic VTE prophylaxis should be strongly considered if there is no active or recent bleeding and if more ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results